A. BlueCove Limited (“BlueCove” or the “Firm”) is an investment adviser with its principal place of business in London, UK. The principal owners and voting shareholders of BlueCove Limited are (i) Alexander Khein, Chief Executive Officer, (ii) The Harroway Limited Partnership, the family limited partnership of BlueCove's Executive Chairman, Hugh Willis, and (iii) Ares Management LLC. The balance of the Firm's shares is beneficially owned by current and former employees of BlueCove. BlueCove wholly-owns BlueCove USA LLC which has a place of business in Boston, MA, USA. BlueCove USA LLC does not undertake any advisory business or any other form of regulated activity. BlueCove is a private limited company appointed by Carne Global AIFM Solutions (C.I.) Limited (“Carne”) to serve as investment manager (the “Investment Manager”) of the BlueCove Equinox Credit Master Fund Limited and related feeder funds (together the “BlueCove Fund" or the “Fund”). Russell Burt, Andrew Linford, and Robert Thomas are the directors (the “Directors,” and each, a “Director”) of the BlueCove Fund, and of the general partners of the limited partnership feeder fund. B. As the Investment Manager of the BlueCove Fund, BlueCove provides discretionary investment management services to a privately offered investment fund intended for sophisticated investors in accordance with the applicable limited partnership agreements, private offering memoranda, investment management agreements and other such agreements (“Offering Documents”). BlueCove currently serves as the investment manager of three funds organized in a master-feeder structure; one master fund (“Master Fund”) that has a domestic feeder (“Domestic Feeder”) and an offshore feeder (“Offshore Feeder”). Both the Domestic Feeder and Offshore Feeder generally invest substantially all of their assets in the Master Fund. C. BlueCove also advises one client that is regulated as an Undertaking for the Collective Investment in Transferable Securities (“UCITS”) as well as a Cayman Islands based Special Purpose Vehicle (“SPV”). D. On 14 September 2021, BlueCove entered

into an Investment Advisory Agreement with the Harbor ETF Trust (on behalf of two of its sub-funds) and Harbor Capital Advisors, Inc. By way of the Investment Advisory Agreement, BlueCove became the sole sub-investment adviser of the Harbor Scientific Alpha Income ETF (NYSE ticker “SIFI”) and the Harbor Scientific Alpha High-Yield ETF (NYSE ticker “SIHY”) (collectively the “Harbor ETFs”). Under the Investment Advisory Agreement, BlueCove is not responsible for the distribution of the ETFs. E. In March 2023, BlueCove entered into an Investment Advisory Agreement to act as subadviser for the Harbor Convertible Securities Fund (NASDAQ ticker “HACSX”). By way of the Investment Advisory Agreement, BlueCove became the sole sub-investment adviser of the Harbor Convertible Securities Fund (together with the Harbor ETFs, the “Harbor Clients”). Under the Investment Advisory Agreement, BlueCove is not responsible for the distribution of the Harbor Convertible Securities Fund. F. On 01 February 2022, BlueCove commenced the management of a segregated mandate for a non- US institutional client (the “Non-US Account”). G. The UCITS client, the SPV client, the Harbor Clients, and the Non-US Account are together referred to as “Other Accounts”. H. The BlueCove Fund and Other Accounts are managed in accordance with their own objectives and are not tailored to any underlying investor (each an "Investor"). Such Investors accept the terms of advisory services as set forth in the Fund’s Offering Documents and in the offering documents, investment management agreements and/or other contractual arrangements relating to the Other Accounts (the “Other Account Mandates”). The Firm has broad investment authority with respect to the BlueCove Fund and Other Accounts and, as such, Investors should consider whether the investment objectives of the BlueCove Fund or Other Accounts are in line with their individual objectives and risk tolerance prior to investment. I. BlueCove does not participate in wrap fee programs. J. As of 31 December 2023, the Firm had regulatory assets under management of $7,613,850,543 all on a discretionary basis.